Off‐label use of rituximab for dermatologic conditions: A single center review

• Main Authors: Emma Porter (Author), Paula Finnegan (Author), Amy Long (Author), John F. Bourke (Author), Michelle Murphy (Author), Cathal O'Connor (Author)
• 格式: 圖書
• 出版: Wiley, 2024-09-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Abstract Background Rituximab (RTX) has been utilised off‐label for a variety of dermatological indications beyond pemphigus vulgaris. Efficacy has been reported in other immunobullous disorders, inflammatory dermatoses and connective tissue diseases. Objectives To assess the off‐label use of RTX in...